Skip to content
Live funding
↑Plinto €2.9M raises a Pre-seed round ↑Huppa €1M raises a Pre-seed round ↑XRlabs €7.3M Seed round led by Playground Global ↑Nouscom €120M Series D+ round led by M Ventures ↑Linkener €7.5M funding round led by Klima Energy Transition Fund (Alantra) ↑CoComply €2.3M funding round led by NPIF II - Mercia Equity Finance ↑Vessla €3.0M Pre-seed round led by Seedcamp ↑Neonomics €3.6M raises a funding round ↑unravel health €3.0M Pre-seed round led by Conduit EIS Impact Fund ↑Microbiotica €42.7M Series C round led by British Business Bank ↑Elevatry €3M raises a Pre-seed round ↑OMass Therapeutics €276.1M Series C round led by Bain Capital Life Sciences ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital
Sesame Summit 2027
Sesamers
← Startups directory

MAASH

Brussels, Belgium

Industrial-scale mycoprotein production for meat alternatives

This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.

€12,150,000
Total raised
-
Valuation
1-10
Employees
2021
Founded

MAASH scales biomass fermentation of fungi to produce mycoprotein at industrial volumes. It supplies the protein to food manufacturers making meat alternatives.

Latest round

Equity - August 1, 2026

Equity - €12,150,000

August 1, 2026

Open roles

MAASH is not hiring through Sesamers right now.

Work here? Claim the profile and post roles.

Claim your profile
Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.